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Introduction
Mitochondrial ATP -ultimately generated by complex V -is almost exclusively the aerobic energy source for all cellular metabolic pathways. The process of ATP production by mitochondrial (mt) ATPase (F1F0-ATP synthase, complex V) is a rotary process driven by an electrochemical proton gradient across the inner mitochondrial membrane.
The human mtATP synthase (mtATPase) is an inner mitochondrial membrane enzyme, consisting of a matrix located F1 catalytic part, which is connected via two stalks with the membraneembedded F0 part for review see (Jonckheere et al., 2012) . The F0 that couples the proton gradient to ATP synthesis by F1 contains among others ATP6 (OMIM #516060) and ATP8 (OMIM #516070), the only two of the 16 subunits of complex V which are encoded by mitochondrial DNA (mtDNA) (Anderson et al., 1981; Wittig and Schaegger, 2008) . Complex V deficiency is rare amongst the OXPHOS deficiencies compromising approximately 1% of muscle samples analysed (Jonckheere et al., 2013 (Jonckheere et al., , 2012 Rodenburg, 2011) . Frequent causes of severe mitochondrial encephalomyopathies are due to dysfunction of mtATPase caused by missense mutations in the MT-ATP6 gene (Table 1) . Mutations in ATP6 are a cause of neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP; MIM:551500), Leber hereditary optic neuropathy (LHON; MIM:535000), Leigh syndrome (LS; MIM:256000) and mitochondrial infantile bilateral striatal necrosis (MIBSN; MIM:500003) (Houstek et al., 2004) . The most frequent mutations in MT-ATP6 are m.8993T > G associated with NARP (Debray et al., 2007; L opez-Gallardo et al., 2014 L opez-Gallardo et al., , 2009 Pastores et al., 1994) , spastic paraplegia-like disorders caused by m.9176T > G ( Kucharczyk et al., 2010; Verny et al., 2011) and m.9185T> C causing sensory neuropathy (Aur e et al., 2013; Pitceathly et al., 2012) .
Here we describe a patient presenting with ataxia and encephalomyopathy caused by a de novo frameshift mutation in MT-ATP6.
Patients' medical report
Already in early infancy the girl attracted attention by a sucking weakness and a failure to thrive with a weight gain below the 3rd centile. Her overall motor development was delayed with sitting independently at 15 months and walking at 22 months of age. Often trivial infections caused a setback in her development. The girl showed a tendency to freeze easily. At the age of 4 months, she was diagnosed with gallstones that persisted during follow-up. Diagnostic work-up for known typical etiologies for gallstones remained negative. At the age of 7 months, the girl showed a delay in motor development with symptoms of ataxia. The head circumference was at 4th centile, her length at 43rd centile and her weight at 4th centile. Blood lactate levels were repeatedly slightly elevated (2e3 mmol/l, normal < 1.6 mmol/l). Standard metabolic testing revealed a lactic aciduria with otherwise normal organic acids in urine and an elevated cerebrospinal fluid (CSF) lactate level (3.5 mmol/l; normal range < 2.1 mmol/l). Blood gas analysis, creatine kinase, ammonia, acylcarnitines and amino acids were normal. A cranial MRI at the age of 2 years was normal. Consequently, a skin and muscle biopsy was performed. The girl recovered only very slowly from anaesthesia with extreme weakness that lasted for several days. At last follow-up at the age of 9 years, she shows a mild mental retardation (WISC-IV-IQ 77) and a mild ataxia with a gross and fine motor coordination disorder. Serial ophthalmological examinations showed astigmatism and exophoria but no signs of pigment retinopathy. Several echocardiographic examinations were normal. She is thermosensitive and has difficulties to adapt to extreme temperatures. With hot weather her body temperature rises up to 38 C and with cold weather falls down to 35 C. Starting at 4 years of age, she had been supplemented with 3 Â 500 mg l-Carnitine per day (ca. 100 mg/kgbw). After four weeks of treatment her daily need of sleep declined remarkably from the previous 16 h to 10e11 h per day. In addition, this supplementation seemed to improve her physical endurance and the dynamics of her movements. Her mother had been a top endurance athlete from the former German Democratic Republic. The family history was unremarkable except for an uncle with mild mental retardation on the maternal side.
Methods

Molecular genetic analysis
Biochemical results of complex V deficiency prompted sequencing of the mitochondria-encoded ATP genes. A C insertion at position m.8612 of the mtDNA (rCRS: NC_012920) was detected by sequencing the ATP6 gene. Quantification of the heteroplasmic degree of the mutation was performed by amplification of a 554 bp fragment specific to the mtDNA using fwd primer nt.8267e8285 and FAM-labelled rev primer nt.8817-8794. A more convenient amplicon was obtained by SspI digestion for fragment analysis on an ABI3100 capillary sequencer. Standard RFLP by inclusion of a mismatch in the primer site (Jackson et al., 2014a) was feasible, since the patient also harboured the additional polymorphism m.8610T > C and m.8614T > C resulting in a homopolymeric cytosine stretch. Therefore, an approach by fragment analysis on a capillary sequencer to discriminate the C insertion from wild type sequence was used to calculate the heteroplasmic degree.
Biochemical and microscopic analyses
Primary fibroblast cultures were established from a skin biopsy as described (Schaller et al., 2011b) . Light and electron microscopic mitochondrial imaging was performed as described before (Jackson et al., 2014c; Schaller et al., 2011a) . Skeletal muscle homogenates were prepared as described previously and the enzymatic activities of the respiratory chain complexes and the mitochondrial matrix marker enzyme citrate synthase were measured spectrophotometrically as described (Jackson et al., 2014b) . Isolated mitochondrial proteins from fibroblast were separated by native PAGE as described (Jackson et al., 2014b) . Antibodies for western blotting included: b-subunit of complex V (Abcam, ab14730), SDHA (Abcam, ab14715) and ATP6 (Abcam, ab101908). Northern blotting to determine the stability and abundance of the ATP6 transcripts was performed as described (Richter et al., 2013) . Briefly, 5 mg of total RNA was run on 1.5% formaldehyde-agarose gels, blotted and probed with a 32 P-ATP-end labelled oligo for RNA14 (ATP8/6 probe: 5 0 -TGGGTGATGAGGAATAGTGTAAGGAG-3). Radioisotope labelling of mitochondrial translation products was analysed as described before (Richter et al., 2015) . Briefly, cells were metabolically labelled with [ 35 S]methionine/cysteine (EasyTag; PerkinElmer) for 30 min in the presence of anisomycin to inhibit cytoplasmic translation. Translation products were separated on a 12e20% gradient SDS-PAGE gel, exposed to a phosphor screen and scanned on a TyphoonFLA7000 (GE Healthcare).
Results
Biochemical measurements of the individual respiratory complexes prompted by the suspicion of a mitochondrial defect were performed from skeletal muscle homogenates and mitochondria enriched fractions of skin fibroblasts. Both tissues showed severe reduction of complex V with a residual activity of 25% in skeletal muscle and 28% in fibroblasts compared to controls (Fig. 1) . Microscopic analysis of mitochondria in patient fibroblasts revealed structurally distorted mitochondria with aberrant cristae formation (Fig. 2 A) . Mitochondrial protein isolated from patient fibroblasts analysed by western blotting of 1D native PAGE using an antibody against the a-subunit of complex V shows impaired complex V assembly in the patient (Fig. 2 B) and ATP6 protein levels to be drastically reduced (Fig. 2 C) . Further electrophoretic analysis of crude mitochondrial fractions from the patient's skeletal muscle by native PAGE (1D BN-PAGE) with subsequent SDS-PAGE (2D-PAGE) confirmed incomplete assembly of complex V in the patient (Fig. 2 D) . Complex V subunits were apparent and were identified as ATPase a, ATPase b and F1 subunits. Due to the enzymatically isolated complex V defect and reduced ATP6 protein levels, the mtDNA-encoded subunits of complex V were sequenced (MT-ATP6/8) and revealed a heteroplasmic C insertion at position 8611 in the MT-ATP6 gene (m.8611_8612insC) ( Fig. 3 A) . Standard RFLP design was impeded by the additional homoplasmic polymorphisms m.8610T > CC and m.8614T > C leading to a 7-mer wild type or 8-mer mutated homopolymer of cytidines with high homology to nuclear background. An mtDNA-specific fragment was amplified and labelled by a last fluorescent cycle (LFC). The 554 bp amplicon was digested using SspI to obtain a convenient fragment of~371 bp for SSCP/HD analysis. SSCP analysis revealed heteroduplexes in the patient's skeletal muscle and fibroblasts, which were absent in controls and the mother's blood ( Fig. 3B and C) . The digested amplicons were analysed on a capillary sequencer and the mutational load of the patient's was calculated to be~60% in skeletal muscle and~80% in fibroblasts. The mutation was not detected in the mothers' blood or buccal cells ( Fig. 3 A) . Subsequent analysis of ATP6 protein levels in isolated mitochondria showed a marked reduction in the patient (Fig. 2 B) . Because mutations in mtDNA can affect mRNA stability, we analysed transcript steady state levels of RNA14/15 and RNA14. Northern analysis indicated no change in either precursor RNA14/ 15 nor in the mature RNA15 steady state abundance (Fig. 4 A) . However, assessment of mitochondrial protein translation by metabolic 35 S-labelling shows a marked decrease of newly synthesised ATP6 in patient' fibroblasts and the accumulation of an aberrant translation product (Fig. 4 B) . 
Discussion
Here we describe a novel MT-ATP6 frameshift mutation in a patient presenting with ataxia and encephalomyopathy. The C insertion at position m.8611 (m.8611-8612insC) truncates the protein to 36 amino acids (p.Pro29LeufsX36). The novel variant was heteroplasmic with a mutational load of~60% in skeletal muscle and~80% in fibroblasts but was absent in the mothers' blood and buccal cells. Biochemical evaluation of individual OXPHOS complexes showed marked complex V deficiency with residual activity of 28% in skeletal muscle and 25% in fibroblasts of the patient compared to controls correlating with the mutational load in both tissues. Protein electrophoretic separation of patient skeletal muscle demonstrated incomplete complex V assembly and revealed accumulated subcomplexes. Incomplete assembly has been shown to be associated with mitochondrial biosynthesis disorders arising from mutations in the mtDNA (Jonckheere et al., 2012) with the mutational load directly correlating with accumulation of subcomplexes of complex V for the NARP mutation m.8993T > C (unpublished results). As the unassembled water soluble F1 part is functional, incomplete ATPase complexes due to mutations affecting ATPase stability are mostly still capable of ATP hydrolysis, but not its synthesis (Dittrich et al., 2003) . Additional to the assembly defect in our patient, mitochondrial translation shows a drastic decrease in ATP6 protein production in conjunction with accumulation of aberrant products.
The vast phenotypic spectrum associated with mutations in ATP6 suggests modifying factors. Interestingly, in NARP patients the nuclear background has been shown to extensively modify the deleterious effect of mtDNA mutations in the MT-ATP6 gene in mutant cells (D'Aurelio et al., 2010) .
Alongside and possibly related to its energetic properties, the mitochondrial ATPase functions as structural element by which dimerization of the assembled ATPase complex shapes formation of inner mitochondrial membrane (Davies et al., 2012) . In accordance with this, ultrastructural analysis of the fibroblasts of the patient reported here revealed abberrant cristae formation. In summary, biochemical analyses reveal incomplete assembly of complex V and reduced activity in skeletal muscle and fibroblasts, distorted mitochondrial ultrastructure and aberrant translation in our patient. In conclusion, these results corroborate the pathogenicity of this novel heteroplasmic mutation and correlate with the disease phenotype. Intriguingly, supplementation of L-carnitine drastically improved the patient's ataxia symptoms, the need for sleep and furthermore the adaptation to temperature extremes. Whether this supplementation was causal for her improvement is uncertain. L-carnitine supplementation effects on the ATP production in tissues dependent on b-oxidation such as skeletal muscle by elevation of free carnitines and thus acts to deplete toxic acyl compounds (Dimauro et al., 2006; Parikh et al., 2009) . This report describes a frameshift mutation in the MT-ATP6 gene causing impaired complex V assembly and deficiency in a patient presenting with ataxia and encephalomyopathy.
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